ResearchSpace

Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide

Show simple item record

dc.contributor.author Adeleke, Oluwatoyin A
dc.contributor.author Tsai, P-C
dc.contributor.author Michniak-Kohn, BB
dc.date.accessioned 2017-11-14T06:21:04Z
dc.date.available 2017-11-14T06:21:04Z
dc.date.issued 2015-10
dc.identifier.citation Adeleke, O.A., Tsai, P-C, and Michniak-Kohn, BB. 2015. Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide. In: American Association of Pharmaceutical Scientists Annual Meeting and Exposition, Orlando, United States of America, October 25-29, 2015 en_US
dc.identifier.uri http://abstracts.aaps.org/Verify/AAPS2015/PosterSubmissions/M1171.pdf
dc.identifier.uri http://hdl.handle.net/10204/9766
dc.description American Association of Pharmaceutical Scientists Annual Meeting and Exposition, Orlando, United States of America, October 25-29, 2015 en_US
dc.description.abstract The purpose of this research is to prepare, characterize as well as assess the ex vivo buccal drug delivery and cytotoxicity of an orally disintegrating film (ODF) loaded with pyrazinamide. Pyrazinamide (solubility = 15 mg/mL at 25°C; log P = -1.884) is an antimicrobial agent indicated for the treatment of tuberculosis (TB) especially in HIV-infected persons with TB co-infection as well as for multidrug and extensively drug resistant TB. en_US
dc.language.iso en en_US
dc.relation.ispartofseries Workflow;16576
dc.subject Antimicrobial agent en_US
dc.subject Drug resistant tuberculosis en_US
dc.subject Pyrazinamide en_US
dc.title Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide en_US
dc.type Conference Presentation en_US
dc.identifier.apacitation Adeleke, O. A., Tsai, P., & Michniak-Kohn, B. (2015). Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide. http://hdl.handle.net/10204/9766 en_ZA
dc.identifier.chicagocitation Adeleke, Oluwatoyin A, P-C Tsai, and BB Michniak-Kohn. "Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide." (2015): http://hdl.handle.net/10204/9766 en_ZA
dc.identifier.vancouvercitation Adeleke OA, Tsai P, Michniak-Kohn B, Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide; 2015. http://hdl.handle.net/10204/9766 . en_ZA
dc.identifier.ris TY - Conference Presentation AU - Adeleke, Oluwatoyin A AU - Tsai, P-C AU - Michniak-Kohn, BB AB - The purpose of this research is to prepare, characterize as well as assess the ex vivo buccal drug delivery and cytotoxicity of an orally disintegrating film (ODF) loaded with pyrazinamide. Pyrazinamide (solubility = 15 mg/mL at 25°C; log P = -1.884) is an antimicrobial agent indicated for the treatment of tuberculosis (TB) especially in HIV-infected persons with TB co-infection as well as for multidrug and extensively drug resistant TB. DA - 2015-10 DB - ResearchSpace DP - CSIR KW - Antimicrobial agent KW - Drug resistant tuberculosis KW - Pyrazinamide LK - https://researchspace.csir.co.za PY - 2015 T1 - Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide TI - Preparation, characterization and ex vivo evaluation of an orally disintegrating film formulation containing pyrazinamide UR - http://hdl.handle.net/10204/9766 ER - en_ZA


Files in this item

Thumbnail
Name: Adeleke_2015.pdf
Size: 16.33Kb
Format: PDF
View/Open

This item appears in the following Collection(s)

Show simple item record